40170011000001107: Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)
\UK product\Virtual medicinal product\Trastuzumab 735mg/250ml in Sodium chloride 0.9% infusion bags\Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)
\UK product\Virtual therapeutic moiety\Trastuzumab\Trastuzumab 735mg/250ml in Sodium chloride 0.9% infusion bags\Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Trastuzumab 735mg/250ml in Sodium chloride 0.9% infusion bags\Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Trastuzumab 735mg/250ml in Sodium chloride 0.9% infusion bags\Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Trastuzumab 735mg/250ml in Sodium chloride 0.9% infusion bags\Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Trastuzumab 735mg/250ml in Sodium chloride 0.9% infusion bags\Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Trastuzumab 735mg/250ml in Sodium chloride 0.9% infusion bags\Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2068901000001116 Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2068921000001111 Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Is a	Trastuzumab 735mg/250ml in Sodium chloride 0.9% infusion bags	true	Inferred relationship	Existential restriction modifier
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction special	true	Inferred relationship	Existential restriction modifier
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Has specific active ingredient	Trastuzumab	true	Inferred relationship	Existential restriction modifier
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Has dispensed dose form	Infusion	true	Inferred relationship	Existential restriction modifier
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	VMP prescribing status (attribute)	Caution - AMP level prescribing advised	true	Inferred relationship	Existential restriction modifier
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag	Has AMP	True	Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2068901000001116	Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2068921000001111	Trastuzumab (Kanjinti) 735mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module